SUBSCRIBE
SUBSCRIBE

Series B

MORE FROM BIOSPACE INSIGHTS
3D illustration of bacteria with their genetic material visible
Series B
George Church Startup Nets $60M to Take Non-Standard Amino Acids to the Clinic
GRO Biosciences will use the Series B funds to launch a Phase I trial for ProGly-Uricase, its investigational therapy for gout.
July 19, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
Pathalys Pharma Secures $105 Million Series B Financing
August 21, 2024
 · 
3 min read
Press Releases
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
August 7, 2024
 · 
4 min read
Press Releases
Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF’s Myeloma Investment Fund; Advances Clinical Development of Lead Program, QXL138AM
August 6, 2024
 · 
4 min read
Press Releases
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development
August 2, 2024
 · 
4 min read
Press Releases
Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform
July 30, 2024
 · 
3 min read
Business
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 8, 2024
 · 
8 min read